⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Matrix Pharma Corp Private Limited and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Matrix Pharma Corp Private Limited
↗Hyderabad, India
Matrix Pharma Corp is a prominent Indian integrated manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates. The company serves as a key partner to global pharmaceutical companies, providing high-quality ingredients across more than 20 therapeutic areas, including antiretrovirals, cardiovascular, and central nervous system treatments.
With a strong emphasis on R&D and manufacturing excellence, the company operates multiple USFDA and EU GMP-certified facilities. It is recognized for its role in improving global access to affordable medicines, particularly in the HIV/ARV space, and maintains a significant global footprint, supplying partners in over 80 countries.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:2022
Ownership:private
Status:operating
FUNDING
Stage:Private Equity
Total Raised:$175M (approx. INR 14.5B)
Investors:Kotak Alternate Asset Managers
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (API supply)
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Global generics and pharma companies (historical ties to Mylan/Viatris legacy)
COMPETITION
Position:Leader
Competitors:Divi's Laboratories, Aurobindo Pharma, Dr. Reddy's Laboratories, Laurus Labs
LEADERSHIP
Key Executives:
Rajender Rao Juvvadi - Chairman & CEO
Pranav Reddy - Promoter Director
LINKS
Website:matrixpharmacorp.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Matrix Pharma Corp Private Limited. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.